NAT10 and esophageal squamous cell carcinoma: Recently, a small-molecule compound (#7586-3507) was found to exert dose-dependent anti-invasion effects on ESCC cells by directly targeting the Khib site in NAT10; 5 μM dramatically decreased the invasion rate to 10–20% [154].